Ah-1.TR1, a nucleic acid aptamer with high affinity for Aeromonas hydrophila, and its application.

By modifying the Aeromonas hydrophila nucleic acid aptamer Ah-1.TR1 and employing a truncation-repetition strategy to form a stable stem-loop structure, the problem of insufficient affinity and stability of existing aptamers was solved, achieving efficient and highly specific detection of Aeromonas hydrophila.

CN122503392BActive Publication Date: 2026-11-10OCEAN UNIV OF CHINA
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202610991598.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2026-07-06
Publication Date
2026-11-10
Estimated Expiration
2046-07-06

AI Technical Summary

Technical Problem

Existing Aeromonas hydrophila nucleic acid aptamers have low affinity (mostly at the micromolar level) and insufficient structural stability, resulting in limited detection sensitivity and making it difficult to meet the needs of rapid and sensitive on-site detection.

Method used

By modifying the original aptamer Ah-1, a truncation-repetition strategy was adopted to remove redundant sequences and repeat key base fragments in situ, forming a more stable stem-loop structure, thereby improving the affinity and structural stability of the nucleic acid aptamer Ah-1.TR1.

Benefits of technology

The affinity dissociation constant of the nucleic acid aptamer Ah-1.TR1 was increased to 97.50 nM, which significantly improved its binding ability with Aeromonas hydrophila. It exhibited good specificity and structural stability and is suitable for rapid and sensitive detection of Aeromonas hydrophila.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122503392B_ABST
    Figure CN122503392B_ABST
Patent Text Reader

Abstract

This invention discloses a nucleic acid aptamer, Ah-1.TR1, with high affinity for Aeromonas hydrophila and its applications, belonging to the field of nucleic acid aptamer technology. The nucleotide sequence of this aptamer is shown in SEQ ID NO.2. This invention obtains a more stable stem-loop structure by truncating and repeating the original aptamer Ah-1, deleting redundant sequences and replicating key base fragments in situ. This aptamer has an affinity dissociation constant of 97.50 nM with Aeromonas hydrophila, representing a 5.58-fold increase in affinity compared to the original aptamer. It also exhibits high specificity, showing no significant binding to common pathogenic bacteria such as Escherichia coli, Staphylococcus aureus, and Vibrio parahaemolyticus. This aptamer can be used to construct biosensors for rapid and sensitive detection of Aeromonas hydrophila.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to a nucleic acid aptamer Ah-1.TR1 with high affinity for Aeromonas hydrophila and its application, belonging to the field of nucleic acid aptamer technology. Background Technology

[0002] Aeromonas hydrophila ( Aeromonas hydrophila Aeromonas hydrophila is a Gram-negative opportunistic pathogen prevalent in aquaculture, capable of infecting various commercially important fish, frogs, shrimp, and crabs. It spreads extremely rapidly, causing large-scale mortality and significant economic losses in farmed populations, and can also infect humans, causing foodborne illnesses. Currently, common detection methods for Aeromonas hydrophila include bacterial culture, polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay (ELISA), but these methods have limitations such as being time-consuming, complex, reliant on specialized equipment, or exhibiting significant batch-to-batch antibody variability, making it difficult to meet the demand for rapid and sensitive on-site detection. Nucleic acid aptamers are single-stranded DNA or RNA molecules that can specifically recognize targets with high affinity. However, existing literature reports that aptamers targeting Aeromonas hydrophila have weak binding affinity, with equilibrium dissociation constants on the order of micromoles, limiting detection sensitivity. Therefore, there is an urgent need to develop a nucleic acid aptamer with high affinity (at the nanomolar level) and strong specificity. Summary of the Invention

[0003] This invention addresses the shortcomings of existing Aeromonas hydrophila nucleic acid aptamers, such as low affinity (mostly at the micromolar level) and insufficient structural stability, which limit detection sensitivity. It provides a nucleic acid aptamer Ah-1.TR1 with high affinity for Aeromonas hydrophila and its applications.

[0004] This invention is achieved through the following technical solution: In a first aspect, the present invention provides a nucleic acid aptamer Ah-1.TR1 with high affinity for Aeromonas hydrophila, the nucleotide sequence of which is shown in SEQ ID NO.2.

[0005] Furthermore, the affinity dissociation constant between the nucleic acid aptamer and Aeromonas hydrophila is 97.50 nM.

[0006] Furthermore, the nucleic acid aptamer showed no significant binding to Escherichia coli, Staphylococcus aureus, Bacillus cereus, Vibrio parahaemolyticus, or Aeromonas salmonidae.

[0007] The nucleic acid aptamer Ah-1.TR1 of this invention is derived from the original aptamer Ah-1. The specific modification process is as follows: the original aptamer targeting Aeromonas hydrophila flagellate protein flgE is obtained by SELEX screening; key base fragments are locked by molecular docking technology; then redundant sequences are deleted and the above key base fragments are repeated in situ to form a more stable stem-loop structure and improve the overall stability of the structure.

[0008] The modification method of this invention has the following advantages: on the one hand, by deleting redundant sequences and adding key base fragments, the binding ability of the aptamer to the target can be effectively enhanced without secondary screening; on the other hand, the stem-loop conformation is reshaped, making the aptamer structure more stable. Compared with the limitations of mutation and other methods in traditional modification methods, this invention adopts a truncation-repetition strategy, which transforms the original aptamer into a more stable key structure by deleting redundant sequences and repeating key bases, providing a new approach for bacterial aptamer modification.

[0009] Secondly, the present invention provides the application of the nucleic acid aptamer Ah-1.TR1 in the detection of Aeromonas hydrophila.

[0010] Thirdly, the present invention provides the application of the nucleic acid aptamer Ah-1.TR1 in the preparation of products for detecting Aeromonas hydrophila.

[0011] Fourthly, the present invention provides a biosensor for detecting Aeromonas hydrophila, the biosensor comprising the aforementioned nucleic acid aptamer as a recognition element.

[0012] Fifthly, the present invention provides a method for detecting Aeromonas hydrophila, comprising contacting the nucleic acid aptamer with the sample to be tested and detecting the binding signal.

[0013] Compared with the prior art, the present invention has the following beneficial effects: High affinity: The affinity dissociation constant (Ka) between the nucleic acid aptamer Ah-1.TR1 of this invention and Aeromonas hydrophila d The affinity was 97.50 nM, which is about 5.58 times higher than that of the original aptamer (544.32 nM), indicating a significant improvement in affinity.

[0014] High specificity: The nucleic acid aptamer Ah-1.TR1 of the present invention showed no significant binding to common foodborne pathogens and dominant bacteria in aquatic products, such as Escherichia coli, Staphylococcus aureus, Bacillus cereus, Vibrio parahaemolyticus, and Aeromonas salmonidae, demonstrating good specificity.

[0015] Structural stability: By truncating and repeating the modification, the stem-ring structure is reshaped, enabling the aptamer to form a more stable key structure, and the overall stability is significantly improved.

[0016] The invention has broad application prospects: the aptamers provided by this invention are easy to synthesize and modify, with small batch-to-batch variations, and are suitable for constructing products such as biosensors. They can achieve rapid, sensitive, and specific detection of Aeromonas hydrophila, and have important application value in the monitoring of aquatic product quality and safety and the prevention and control of foodborne diseases. Attached Figure Description

[0017] The accompanying drawings, which form part of this specification, are used to provide a further understanding of the invention. The illustrative embodiments of the invention and their descriptions are used to explain the invention and do not constitute an improper limitation of the invention.

[0018] Figure 1 Affinity test results for the original aptamer Ah-1.

[0019] Figure 2 Secondary structure prediction of the primitive aptamer Ah-1.

[0020] Figure 3 Affinity determination results of the modified aptamer Ah-1.TR1.

[0021] Figure 4 Secondary structure prediction of the modified aptamer Ah-1.TR1.

[0022] Figure 5 Affinity determination results of the modified aptamer Ah-1.TR2.

[0023] Figure 6 Secondary structure prediction of the modified aptamer Ah-1.TR2.

[0024] Figure 7 Affinity determination results of modified aptamer Ah-1.TR3.

[0025] Figure 8 Secondary structure prediction of the modified aptamer Ah-1.TR3.

[0026] Figure 9 Affinity determination results of the modified aptamer Ah-1.TR4.

[0027] Figure 10 Secondary structure prediction of the modified aptamer Ah-1.TR4.

[0028] Figure 11 Affinity determination results of modified aptamer Ah-1.TR5.

[0029] Figure 12 Secondary structure prediction of the modified aptamer Ah-1.TR5.

[0030] Figure 13Laser confocal imaging of different bacteria bound to the modified aptamer Ah-1.TR1; (a): Escherichia coli; (b): Staphylococcus aureus; (c): Bacillus cereus; (d): Vibrio parahaemolyticus; (e): Aeromonas salmonidae; (f): Aeromonas hydrophila.

[0031] Figure 14 Binding controls of blank samples, random sequences, and modified aptamer Ah-1.TR1 with Aeromonas hydrophila.

[0032] Figure 15 Changes in fluorescence intensity after interaction of different concentrations of random sequences with Aeromonas hydrophila.

[0033] Figure 16 Flow cytometry analysis of the modified aptamer Ah-1.TR1 binding to different bacteria. Detailed Implementation

[0034] The present invention will be further described below with reference to embodiments. However, the scope of the present invention is not limited to the following embodiments. Those skilled in the art will understand that various changes and modifications can be made to the present invention without departing from the spirit and scope thereof.

[0035] Unless otherwise specified, the instruments, reagents, and materials used in the following embodiments are all conventional instruments, reagents, and materials already available in the prior art and can be obtained through legitimate commercial channels. Unless otherwise specified, the experimental methods and detection methods used in the following embodiments are all conventional experimental methods and detection methods already available in the prior art.

[0036] This invention employs flow cytometry combined with fluorescent labeling technology to determine the affinity of aptamers for targets. Flow cytometry is a biological technique used to study the characteristics of cells and biological particles. By analyzing the average and median fluorescence intensity of positive bacteria, the binding capacity of the bacteria is indirectly assessed. A higher average fluorescence intensity indicates a greater number of molecules bound to the cell surface, indicating a stronger binding capacity. Software analysis can further determine the affinity dissociation constant (Kd) of the aptamer for the target. The test conditions were: medium flow rate; 10,000 display events; 1 SIT rinse; forward scatter voltage of 500.0, threshold of 10,000; side scatter voltage of 472.0, threshold of 10,000; experimental group: positive bacteria group; control group: bacterial blank tube.

[0037] The Aeromonas hydrophila, Escherichia coli, Staphylococcus aureus, Bacillus cereus, Vibrio parahaemolyticus, and Aeromonas salmonida used in this embodiment are all conventional strains in the field and can be obtained by the public through commercial channels or strain preservation centers.

[0038] Example 1: Determination of affinity and prediction of secondary structure of the original aptamer Ah-1 The stem-loop structure is a fundamental conformation widely present in aptamers. To obtain a more stable and more compatible modified aptamer, this invention selects Ah-1, an aptamer with a typical multi-stem-loop structure targeting Aeromonas hydrophila, as the original aptamer for modification and optimization. Its nucleotide sequence is shown in SEQ ID NO.1, as follows (direction 5'-3'): AACACGACCAAACTGTGGCAGCCACAGTTCGTGCTTGTGGGC; a total of 42 bases.

[0039] The affinity of the primitive aptamer Ah-1 was determined. The results of the affinity determination of the primitive aptamer Ah-1 are as follows: Figure 1 As shown in the figure. The results indicate that the primitive aptamer Ah-1 exhibits good affinity for Aeromonas hydrophila and is suitable for subsequent experiments.

[0040] To determine the key base fragments for aptamer-target binding, the amino acid sequence (WP_011706641.1) of Aeromonas hydrophila flagellar hook protein flgE was retrieved from the NCBI database (https: / / www.ncbi.nlm.nih.gov / ), and the tertiary structure of the target protein was predicted using the online tool Alphafold (https: / / alphafoldserver.com / signin). Simultaneously, the secondary structure of the primitive aptamer was predicted using the online tool "TheUNAFoldweb server," and the tertiary structure was predicted using RNAcomposer. Multiple molecular dockings were performed using the HDOCK Server online tool to obtain the high-probability distribution positions of the key sites on the primitive aptamer, namely C13 to G17, C23 to G28, and G37 to G41. The results are as follows: Figure 2 As shown in the figure, the areas marked by the box lines are key base fragments, hereinafter referred to as H1 and H2. Among them, C13 to G17 and C23 to G28 together constitute H1, and G37 to G41 constitute H2.

[0041] Example 2: Modification of the original aptamer Ah-1.TR1 To obtain a modified aptamer with higher affinity, the original aptamer Ah-1 was modified using a truncation-replication principle for optimization. For ease of description, the A1 to A2 portions of the original aptamer were designated as region 1, the stem-loop structure formed between C3 to A12 and T28 to G33 as region 2, the stem-loop structure formed between C13 to G27 as region 3, and C34 to C42 as region 4 (the above position numbers are based on the sequence shown in SEQ ID NO.1). Region 2 of the original aptamer was deleted, and region 3 was copied in situ to obtain the modified aptamer Ah-1.TR1.

[0042] The nucleotide sequence of the modified aptamer Ah-1.TR1 is shown in SEQ ID NO.2, as shown below (direction 5'-3'): AACTGTGGCACTGTGGCAGCCACAGGCCACAGCTTGTGGGC; a total of 41 bases.

[0043] Affinity testing and verification were performed on the modified aptamer. The affinity test results for the modified aptamer Ah-1.TR1 are as follows: Figure 3 As shown, the secondary structure prediction of the modified aptamer Ah-1.TR1 is as follows: Figure 4 As shown. The modified aptamer has a 5.58-fold increased affinity compared to the original aptamer (based on the Kd ratio, the original aptamer Ah-1 has a K... d The K of the improved Ah-1.TR1 is 544.32 nM. d (97.50 nM).

[0044] Example 3: Modification of the original aptamer Ah-1.TR2 Based on the zoning definition (zones 1 to 4) in Example 2, zones 2 and 4 of the original aptamer were deleted, and zone 3 was copied in situ in zone 4 to obtain the modified aptamer Ah-1.TR2.

[0045] The nucleotide sequence of the modified aptamer Ah-1.TR2 is shown in SEQ ID NO.3, as shown below (direction 5'-3'): AACTGTGGCACTGTGGCAGCCACAGGCCACAGCTTGTGGGCCTTGTGGGC; a total of 50 bases.

[0046] Affinity testing and verification were performed on the modified aptamer. The affinity test results for the modified aptamer Ah-1.TR2 are as follows: Figure 5 As shown, the secondary structure prediction of the modified aptamer Ah-1.TR2 is as follows: Figure 6 As shown. The modified aptamer has a 3.78-fold increased affinity compared to the original aptamer (in Kelvin).d Ratio meter, K of primitive aptamer Ah-1 d The K of the improved Ah-1.TR2 is 544.32 nM. d (143.99 nM).

[0047] Example 4: Modification of the original aptamer Ah-1.TR3 Based on the regional definition (regions 1 to 4) in Example 2, the stem-loop structure of region 2 of the original aptamer was deleted and the key base fragment H1 as defined in Example 1 was copied in situ to obtain the modified aptamer Ah-1.TR3.

[0048] The nucleotide sequence of the modified aptamer Ah-1.TR3 is shown in SEQ ID NO.4, as shown below (direction 5'-3'): AACTGTGGACCAAACTGTGGCAGCCACAGTTCCACAGCTTGTGGGC; a total of 46 bases.

[0049] Affinity testing and verification were performed on the modified aptamer. The affinity test results for the modified aptamer Ah-1.TR3 are as follows: Figure 7 As shown, the secondary structure prediction of the modified aptamer Ah-1.TR3 is as follows: Figure 8 As shown. The modified aptamer has a 3.75-fold increased affinity compared to the original aptamer (in K). d Ratio meter, K of primitive aptamer Ah-1 d The K of the improved Ah-1.TR3 is 544.32 nM. d (145.25 nM).

[0050] Example 5: Modification of the original aptamer Ah-1.TR4 Based on the regional definition (regions 1 to 4) in Example 2, region 2 of the original aptamer was deleted and region 3 was copied in situ. Meanwhile, region 4 only retained the key base fragments H2 and C42 as defined in Example 1, resulting in the modified aptamer Ah-1.TR4.

[0051] The nucleotide sequence of the modified aptamer Ah-1.TR4 is shown in SEQ ID NO.5, as shown below (direction 5'-3'): AAGCTGTGCTGTGGCAGCCACAGCACAGCGTGGGC; a total of 35 bases.

[0052] Affinity testing and verification were performed on the modified aptamer. The affinity test results for the modified aptamer Ah-1.TR4 are as follows: Figure 9 As shown, the secondary structure prediction of the modified aptamer Ah-1.TR4 is as follows: Figure 10 As shown. The modified aptamer has a 3.40-fold increased affinity compared to the original aptamer (in K). d Ratio meter, K of primitive aptamer Ah-1 d The K of the improved Ah-1.TR4 is 544.32 nM. d (160.26 nM).

[0053] Example 6: Modification of the original aptamer Ah-1.TR5 Based on the regional definition (regions 1 to 4) in Example 2, region 2 of the original aptamer was deleted and region 3 was copied in situ. Meanwhile, region 4 only retained the key base fragment H2 as defined in Example 1 and was copied in situ to obtain the modified aptamer Ah-1.TR5.

[0054] The nucleotide sequence of the modified aptamer Ah-1.TR5 is shown in SEQ ID NO.6, as shown below (direction 5'-3'): AACTGTGGTGTCGCAGCGACACCACAGAGTGGGGTGGG; a total of 38 bases.

[0055] Affinity testing and verification were performed on the modified aptamer. The affinity test results for the modified aptamer Ah-1.TR5 are as follows: Figure 11 As shown, the secondary structure prediction of the modified aptamer Ah-1.TR5 is as follows: Figure 12 As shown. The modified aptamer has a 4.93-fold increased affinity compared to the original aptamer (in Kelvin). d Ratio meter, K of primitive aptamer Ah-1 d The K of the improved Ah-1.TR5 is 544.32 nM. d (110.50 nM).

[0056] The affinity determination results of the original aptamer Ah-1 and the modified aptamers Ah-1.TR1 to Ah-1.TR5 are shown in Table 1.

[0057] Table 1. Affinity determination results of different aptamers aptamers <![CDATA[ K d (nM)]]> ΔG (kJ / mol) Ah-1 544.32 ± 63.78 -10.24 Ah-1.TR1 97.50 ± 9.61 -13.81 Ah-1.TR2 143.99 ± 2.88 -16.59 Ah-1.TR3 145.25 ± 5.72 -12.73 Ah-1.TR4 160.26 ± 25.92 -15.92 Ah-1.TR5 110.50 ± 0.71 -14.84 As shown in Table 1, the truncated-repetitive aptamers all exhibit high affinity and stability. Among them, the improved aptamer Ah-1.TR1 shows the most significant improvement in affinity, with an affinity dissociation constant of 97.50 nM with Aeromonas hydrophila, which is 5.58 times higher than that of the original aptamer. This invention formally names it aptamer Ah-1.TR1.

[0058] Example 7 Specificity determination of modified aptamer Ah-1.TR1 (1) Laser confocal verification of aptamer specificity To determine the specificity of the aptamer Ah-1.TR1 for Aeromonas hydrophila, it was incubated with six bacteria: Escherichia coli, Staphylococcus aureus, Bacillus cereus, Vibrio parahaemolyticus, Aeromonas salmonidae, and Aeromonas hydrophila, and analyzed by laser confocal microscopy. Figure 13 As shown, bright green fluorescence was observed when the aptamer bound to the target bacteria. No obvious green fluorescence was observed when the aptamer bound to non-target bacteria. This demonstrates that the aptamer Ah-1.TR1 has strong specificity for Aeromonas hydrophila.

[0059] (2) Random sequence verification of aptamer specificity The binding of the aptamer Ah-1.TR1 to Aeromonas hydrophila was validated by testing a random sequence (A4-N). A4-N consisted of a random fragment of 41 bases (A, C, G, or T) (the same number of bases as Ah-1.TR1). Flow cytometry combined with fluorescent labeling was used to detect the binding of A4-N to Aeromonas hydrophila. Results: The binding of blank samples, random sequences, and modified aptamer Ah-1.TR1 to Aeromonas hydrophila was compared as follows. Figure 14 As shown, the random sequence does not bind to Aeromonas hydrophila; the fluorescence intensity diagrams after interaction of different concentrations of random sequence with Aeromonas hydrophila are shown in the figure. Figure 15 As shown, no significant change in fluorescence intensity was observed with increasing random sequence concentrations (100, 200, 400, 800, 1000, 1600, 2000 nM). This indicates that the affinity of the aptamers of this invention depends on the enhancing effect of "truncated-repeated" binding, rather than random combination. Truncated-repeated aptamers can achieve recognition of multiple binding sites, thereby enhancing the binding strength with the target.

[0060] (3) Flow cytometry to verify the specificity of aptamers The aptamer Ah-1.TR1 was used in flow cytometry to detect the fluorescent labeling of *Escherichia coli*, *Staphylococcus aureus*, *Bacillus cereus*, *Vibrio parahaemolyticus*, *Aeromonas salmonidae*, and *Aeromonas hydrophila*. The specific binding analysis of the modified aptamer Ah-1.TR1 based on flow cytometry is shown below. Figure 16 As shown in the figure. The experimental results showed that the aptamer Ah-1.TR1 did not show significant changes in fluorescence intensity for any of the five non-target bacteria, indicating that the modified aptamer Ah-1.TR1 has a high affinity for Aeromonas hydrophila, but does not specifically bind to common foodborne pathogens and dominant bacteria in aquatic products.

[0061] The above embodiments are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above embodiments. Any changes, modifications, substitutions, combinations, or simplifications made without departing from the spirit and principle of the present invention shall be considered equivalent substitutions and shall be included within the protection scope of the present invention.

Claims

1. A nucleic acid aptamer Ah-1.TR1 with high affinity for Aeromonas hydrophila, characterized in that, The nucleotide sequence of the nucleic acid aptamer is shown in SEQ ID NO.

2.

2. The nucleic acid aptamer Ah-1.TR1 according to claim 1, characterized in that, The affinity dissociation constant of the nucleic acid aptamer Ah-1.TR1 with Aeromonas hydrophila is 97.50 nM.

3. The nucleic acid aptamer Ah-1.TR1 according to claim 1, characterized in that, The nucleic acid aptamer Ah-1.TR1 showed no significant binding to Escherichia coli, Staphylococcus aureus, Bacillus cereus, Vibrio parahaemolyticus, or Aeromonas salmonidae.

4. The use of the nucleic acid aptamer Ah-1.TR1 according to claim 1 in the preparation of products for detecting Aeromonas hydrophila.

5. A biosensor for detecting Aeromonas hydrophila, characterized in that, The biosensor includes the nucleic acid aptamer Ah-1.TR1 as a recognition element as described in claim 1.

Citation Information

Patent Citations

  • Aeromonas hydrophila nucleic acid aptamer as well as screening method and application thereof

    CN122146708A

  • Nucleic acid sequences and combination thereof for sensitive amplification and detection of bacterial and fungal sepsis pathogens

    US20110151453A1